3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
3
Active not recruiting
3
Withdrawn
1
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Melanoma
7
Neoplasms
3
Uveal Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Carcinoma, Anaplastic
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Recurrence
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Gastrointestinal Stromal Tumors
1
Interventions
vandetanib
1
trametinib
1
fosbretabulin
1
dabrafenib
1
combretastatin
1
ceritinib
1
Paclitaxel
1
Docetaxel
1
Carboplatin
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Thyroid Carcinoma, Anaplastic
×
trametinib
×
Clear all
NCT04739566
2024-03-25
ANAPLAST-NEO
Saint Petersburg State University, Russia
Phase 2
Withdrawn